文献速递前列腺癌

患者报告健康状况、合并症负担与前列腺癌治疗

Patient-reported Health Status, Comorbidity Burden, and Prostate Cancer Treatment.
PubMed 文献 · Urology · 2020-12-19

本研究基于SEER-Medicare数据,纳入2724例65-84岁局限性前列腺癌男性,分析患者报告健康状况与NCI合并症评分对治疗的影响。调整人口学和癌症风险后,患者报告健康状况与治疗显著相关,而合并症评分关系不一致。结论认为患者报告健康状况引导治疗方向合理,合并症关系不一致。

要点

  • 患者报告健康状况差者较少接受治疗(OR 0.71,95%CI 0.56-0.90)。
  • 年轻中高危患者健康状况差者较少选择前列腺切除术而接受放疗。
  • NCI合并症评分1分者反而更常接受治疗(OR 1.37,95%CI 1.11-1.70)。

核心结论

  • 患者报告健康状况引导前列腺癌治疗方向合理,而合并症与治疗关系不一致。

研究设计与样本

  • 利用SEER数据链接Medicare索赔和CAHPS调查,识别2004-2013年诊断的65-84岁局限性前列腺癌男性2724例。

主要发现

  • 43.0%患者自评健康状况极好/很好,62.7%合并症评分为0。
  • 与极好/很好相比,差/一般健康状况者较少接受治疗(OR 0.71,95%CI 0.56-0.90)。
  • 年轻中高危患者中,良好(OR 0.60,95%CI 0.41-0.88)或一般/差(OR 0.49,95%CI 0.30-0.79)健康状况者较少接受前列腺切除术而非放疗。
  • NCI合并症评分1分者较0分者更常接受治疗(OR 1.37,95%CI 1.11-1.70)。

临床怎么用

  • 临床决策中应重视患者报告的健康状况,其可能比合并症评分更一致地影响治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether patient-reported health status, more so than comorbidity, influences treatment in men with localized prostate cancer. METHODS: Using Surveillance, Epidemiology, and End Results data linked with Medicare claims and CAHPS surveys, we identified men aged 65-84 diagnosed with localized prostate cancer from 2004 to 2013 and ascertained their National Cancer Institute (NCI) comorbidity score and patient-reported health status. Adjusting for demographics and cancer risk, we examined the relationship between these measures and treatment for the overall cohort, low-risk men aged 65-74, intermediate/high-risk men aged 65-74, and men aged 75-84. RESULTS: Among 2724 men, 43.0% rated their overall health as Excellent/Very Good, while 62.7% had a comorbidity score of 0. Beyond age and cancer risk, patient-reported health status was significantly associated with treatment. Compared to men reporting Excellent/Very Good health, men in Poor/Fair health less often received treatment (odds ratio [OR] 0.71, 95% confidence interval [CI] 0.56-0.90). Younger men with intermediate/high-risk cancer in Good (OR 0.60, 95% CI 0.41-0.88) or Fair/Poor (OR 0.49, 95% CI 0.30-0.79) health less often underwent prostatectomy vs radiation compared to men in Excellent/Very Good health. In contrast, men with NCI comorbidity score of 1 more often received treatment (OR 1.37, 95% CI 1.11-1.70) compared to men with NCI comorbidity score of 0. CONCLUSION: Patient-reported health status drives treatment for prostate cancer in an appropriate direction whereas comorbidity has an inconsistent relationship. Greater understanding of this interplay between subjective and empiric assessments may facilitate more shared decision-making in prostate cancer care.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. McMahon S, Basak R, Zhou X, et al. Patient-reported Health Status, Comorbidity Burden, and Prostate Cancer Treatment. Urology. 2020. PMID: 33352164. doi:10.1016/j.urology.2020.12.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。